Latest news
Did NewAmsterdam Pharma’s (NAMS) Sharp Revenue Drop and Wider Loss Just Shift Its Investment Narrative? - simplywall.stsimplywall.st · Tue, 11 Aug 2026 11:31:14 GMTThree New Hires Receive Stock Awards With Up to 4-Year Vesting - Stock TitanStock Titan · Thu, 06 Aug 2026 20:01:00 GMTNewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:55:03 GMTNewAmsterdam Pharma reports $3.7 million second quarter revenue - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 11:16:00 GMTNAMS|NewAmsterdam Pharma Company NV|Price:27.372|Chg%:-0.418 - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTNewAmsterdam Pharma to Discuss Cholesterol Drug at Aug. 5 Event - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT